Enerpac Tool(US:EPAC) Globenewswireยท2025-10-15 21:00Core Insights - Enerpac Tool Group Corp. reported record revenue for fiscal 2025, achieving net sales of $616.9 million, a 4.6% increase from the previous year, driven by growth in the Industrial Tools & Services segment and Cortland Biomedical [6][12][20] - The company maintained strong cash flow, generating $111.3 million from operating activities, and returned $71 million to investors through share repurchases and dividends while preserving a robust balance sheet [4][10][12] - The integration of the acquired DTA business is progressing well, with a strong sales funnel for cross-selling opportunities [4] Financial Performance - For the fourth quarter of fiscal 2025, net sales were $167.5 million, a 5.5% increase year-over-year, although organic sales decreased by 1.8% [11][12] - Net earnings for fiscal 2025 were $92.7 million, with diluted EPS of $1.70, reflecting a 13% increase compared to the previous year [9][12] - Adjusted EBITDA for fiscal 2025 was $153.6 million, up 4% from $147.5 million in fiscal 2024, with an adjusted EBITDA margin of 24.9% [9][12] Segment Performance - The Industrial Tools & Services segment saw a 4.3% increase in net sales, supported by the DTA acquisition, while organic growth was modest at 0.5% [7][12] - Cortland Biomedical experienced significant growth of 14.8%, contributing positively to overall sales [6][12] - Gross profit margin for the company declined slightly to 50.5%, impacted by service margins and the inclusion of DTA, but was partially offset by stronger margins in Heavy Lifting Technology and Cortland Biomedical [7][9] Cost Management - Selling, general and administrative expenses (SG&A) decreased by $3.2 million year-over-year to $172.8 million, primarily due to the absence of ASCEND-related charges [8][12] - Adjusted SG&A expenses increased slightly to $165.5 million but declined as a percentage of revenues, indicating improved efficiency [8][12] Shareholder Returns - The company returned $69 million to shareholders through share repurchases in the fourth quarter, with a new $200 million share repurchase program authorized on October 10, 2025 [12][18] - Cumulative share repurchases since March 2022 have totaled approximately $240 million [17][18] Outlook - For fiscal 2026, the company projects net sales between $635 million and $655 million, with adjusted EBITDA expected to range from $158 million to $168 million [20] - The guidance reflects anticipated organic growth of 1% to 4% and assumes stable foreign exchange rates and regulatory conditions [20]